Theralase Technologies Inc. (TLTFF)
USD 0.19
(4.11%)
USD 0.19
(4.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.37 Million CAD | 28.36% |
| 2022 | 1.06 Million CAD | 22.12% |
| 2021 | 874.79 Thousand CAD | 2.06% |
| 2020 | 857.13 Thousand CAD | -46.92% |
| 2019 | 1.61 Million CAD | -37.07% |
| 2018 | 2.56 Million CAD | 100.9% |
| 2017 | 1.27 Million CAD | 132.32% |
| 2016 | 549.74 Thousand CAD | -30.03% |
| 2015 | 785.66 Thousand CAD | 53.52% |
| 2014 | 511.75 Thousand CAD | -44.43% |
| 2013 | 920.98 Thousand CAD | -23.08% |
| 2012 | 1.19 Million CAD | 25.29% |
| 2011 | 955.71 Thousand CAD | 35.3% |
| 2010 | 706.35 Thousand CAD | 0.35% |
| 2009 | 703.9 Thousand CAD | -11.44% |
| 2008 | 794.78 Thousand CAD | 137.16% |
| 2007 | 335.12 Thousand CAD | 6.81% |
| 2006 | 313.74 Thousand CAD | 97.34% |
| 2005 | 158.98 Thousand CAD | -1.57% |
| 2004 | 161.52 Thousand CAD | -25.13% |
| 2003 | 215.74 Thousand CAD | 1912.38% |
| 2002 | 10.72 Thousand CAD | 12.16% |
| 2001 | 9559.00 CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.72 Million CAD | 35.41% |
| 2024 Q1 | 1.27 Million CAD | -6.98% |
| 2023 Q4 | 1.37 Million CAD | 0.23% |
| 2023 FY | 1.37 Million CAD | 28.36% |
| 2023 Q2 | 1.34 Million CAD | -0.58% |
| 2023 Q3 | 1.36 Million CAD | 1.89% |
| 2023 Q1 | 1.35 Million CAD | 26.44% |
| 2022 FY | 1.06 Million CAD | 22.12% |
| 2022 Q4 | 1.06 Million CAD | -15.01% |
| 2022 Q3 | 1.25 Million CAD | -11.05% |
| 2022 Q1 | 1.33 Million CAD | 52.58% |
| 2022 Q2 | 1.41 Million CAD | 5.87% |
| 2021 Q4 | 874.79 Thousand CAD | 6.41% |
| 2021 FY | 874.79 Thousand CAD | 2.06% |
| 2021 Q1 | 756.84 Thousand CAD | -11.7% |
| 2021 Q2 | 861.84 Thousand CAD | 13.87% |
| 2021 Q3 | 822.07 Thousand CAD | -4.62% |
| 2020 Q1 | 1.27 Million CAD | -20.78% |
| 2020 Q2 | 867 Thousand CAD | -32.22% |
| 2020 FY | 857.13 Thousand CAD | -46.92% |
| 2020 Q4 | 857.13 Thousand CAD | -9.24% |
| 2020 Q3 | 944.42 Thousand CAD | 8.93% |
| 2019 Q2 | 1.27 Million CAD | 31.87% |
| 2019 Q3 | 947.52 Thousand CAD | -25.89% |
| 2019 Q1 | 969.58 Thousand CAD | -62.21% |
| 2019 Q4 | 1.61 Million CAD | 70.41% |
| 2019 FY | 1.61 Million CAD | -37.07% |
| 2018 Q2 | 1.46 Million CAD | -20.78% |
| 2018 FY | 2.56 Million CAD | 100.9% |
| 2018 Q4 | 2.56 Million CAD | -0.95% |
| 2018 Q1 | 1.84 Million CAD | 44.34% |
| 2018 Q3 | 2.59 Million CAD | 77.37% |
| 2017 Q2 | 592.62 Thousand CAD | 14.4% |
| 2017 FY | 1.27 Million CAD | 132.32% |
| 2017 Q4 | 1.27 Million CAD | 145.42% |
| 2017 Q3 | 520.38 Thousand CAD | -12.19% |
| 2017 Q1 | 518.03 Thousand CAD | -5.77% |
| 2016 Q3 | 563.22 Thousand CAD | 34.28% |
| 2016 Q2 | 419.45 Thousand CAD | -40.46% |
| 2016 Q1 | 704.44 Thousand CAD | -10.34% |
| 2016 Q4 | 549.74 Thousand CAD | -2.39% |
| 2016 FY | 549.74 Thousand CAD | -30.03% |
| 2015 FY | 785.66 Thousand CAD | 53.52% |
| 2015 Q4 | 785.66 Thousand CAD | -4.59% |
| 2015 Q3 | 823.49 Thousand CAD | 142.38% |
| 2015 Q1 | 474.16 Thousand CAD | -7.34% |
| 2015 Q2 | 339.75 Thousand CAD | -28.35% |
| 2014 FY | 511.75 Thousand CAD | -44.43% |
| 2014 Q4 | 511.75 Thousand CAD | 35.77% |
| 2014 Q3 | 376.92 Thousand CAD | 16.85% |
| 2014 Q2 | 322.58 Thousand CAD | -47.23% |
| 2014 Q1 | 611.33 Thousand CAD | -33.62% |
| 2013 FY | 920.98 Thousand CAD | -23.08% |
| 2013 Q4 | 920.98 Thousand CAD | -46.2% |
| 2013 Q2 | 1.64 Million CAD | 12.36% |
| 2013 Q1 | 1.46 Million CAD | 22.3% |
| 2013 Q3 | 1.71 Million CAD | 4.03% |
| 2012 Q2 | 721.15 Thousand CAD | -31.87% |
| 2012 Q1 | 1.05 Million CAD | 10.75% |
| 2012 FY | 1.19 Million CAD | 25.29% |
| 2012 Q3 | 848.97 Thousand CAD | 17.72% |
| 2012 Q4 | 1.19 Million CAD | 41.04% |
| 2011 FY | 955.71 Thousand CAD | 35.3% |
| 2011 Q1 | 734.03 Thousand CAD | 3.92% |
| 2011 Q2 | 789.67 Thousand CAD | 7.58% |
| 2011 Q4 | 955.71 Thousand CAD | -14.02% |
| 2011 Q3 | 1.11 Million CAD | 40.77% |
| 2010 Q2 | 550.5 Thousand CAD | 1.16% |
| 2010 FY | 706.35 Thousand CAD | 0.35% |
| 2010 Q4 | 706.35 Thousand CAD | 3.01% |
| 2010 Q1 | 544.17 Thousand CAD | -22.69% |
| 2010 Q3 | 685.73 Thousand CAD | 24.56% |
| 2009 FY | 703.9 Thousand CAD | -11.44% |
| 2009 Q1 | 779.58 Thousand CAD | -1.91% |
| 2009 Q2 | 827.24 Thousand CAD | 6.11% |
| 2009 Q3 | 744.4 Thousand CAD | -10.01% |
| 2009 Q4 | 703.9 Thousand CAD | -5.44% |
| 2008 Q1 | 455.45 Thousand CAD | 35.91% |
| 2008 FY | 794.78 Thousand CAD | 137.16% |
| 2008 Q4 | 794.78 Thousand CAD | 48.59% |
| 2008 Q3 | 534.88 Thousand CAD | 4.95% |
| 2008 Q2 | 509.66 Thousand CAD | 11.9% |
| 2007 Q1 | 281.35 Thousand CAD | -10.32% |
| 2007 Q2 | 297.67 Thousand CAD | 5.8% |
| 2007 Q4 | 335.12 Thousand CAD | 94.1% |
| 2007 Q3 | 172.65 Thousand CAD | -42.0% |
| 2007 FY | 335.12 Thousand CAD | 6.81% |
| 2006 Q4 | 313.74 Thousand CAD | 161.96% |
| 2006 Q1 | 261.6 Thousand CAD | 64.54% |
| 2006 Q2 | 164.3 Thousand CAD | -37.19% |
| 2006 FY | 313.74 Thousand CAD | 97.34% |
| 2006 Q3 | 119.76 Thousand CAD | -27.11% |
| 2005 FY | 158.98 Thousand CAD | -1.57% |
| 2005 Q1 | 150.12 Thousand CAD | -7.05% |
| 2005 Q2 | 89.71 Thousand CAD | -40.24% |
| 2005 Q3 | 97.13 Thousand CAD | 8.28% |
| 2005 Q4 | 158.98 Thousand CAD | 63.67% |
| 2004 Q4 | 161.52 Thousand CAD | -8.43% |
| 2004 Q3 | 176.38 Thousand CAD | -9.13% |
| 2004 Q1 | 192.9 Thousand CAD | -10.59% |
| 2004 FY | 161.52 Thousand CAD | -25.13% |
| 2004 Q2 | 194.1 Thousand CAD | 0.62% |
| 2003 Q3 | 20.59 Thousand CAD | 17.53% |
| 2003 Q4 | 215.74 Thousand CAD | 947.42% |
| 2003 Q2 | 17.52 Thousand CAD | 2.92% |
| 2003 Q1 | 17.02 Thousand CAD | 58.83% |
| 2003 FY | 215.74 Thousand CAD | 1912.38% |
| 2002 Q4 | 10.72 Thousand CAD | 241.65% |
| 2002 FY | 10.72 Thousand CAD | 12.16% |
| 2002 Q1 | 10.28 Thousand CAD | 0.0% |
| 2002 Q2 | 18.34 Thousand CAD | 78.27% |
| 2002 Q3 | 3138.00 CAD | -82.89% |
| 2001 FY | 9559.00 CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | 93.097% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 35.252% |
| Össur hf. | 688.8 Million USD | 99.801% |
| QHSLab, Inc. | 2.05 Million USD | 33.333% |
| Wellstar International, Inc. | 55.99 Million USD | 97.551% |
| Össur hf. | 688.8 Million USD | 99.801% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | 53.487% |
| Aurora Spine Corporation | 6.65 Million USD | 79.389% |
| BrainsWay Ltd. | 15.31 Million USD | 91.045% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | 91.75% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 97.009% |
| Vivos Inc. | 245 Thousand USD | -459.731% |
| Kelyniam Global, Inc. | 1.01 Million USD | -35.385% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -397.567% |
| Zecotek Photonics Inc. | 5.86 Million USD | 76.632% |
| Avitar, Inc. | 11.59 Million USD | 88.171% |
| Nanomix Corporation | 14.81 Million USD | 90.743% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 91.472% |
| Theraclion SA | 13.01 Million EUR | 89.464% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | 32.312% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 62.129% |
| Lombard Medical, Inc. | 53.79 Million USD | 97.451% |
| ALR Technologies Inc. | 24.5 Million USD | 94.404% |
| Stratec SE | 271.97 Million USD | 99.496% |
| Vycor Medical, Inc. | 4.31 Million USD | 68.239% |
| Heart Tronics, Inc. | 1.09 Million USD | -25.263% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.945% |
| VMS Rehab Systems, Inc. | 201.36 USD | -680950.854% |
| NewCardio, Inc. | 6.01 Million USD | 77.192% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 74.952% |
| Ingen Technologies, Inc. | 5.7 Million USD | 75.981% |
| Odyssey Group International, Inc. | 6.61 Million USD | 79.259% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 44.022% |
| Wellness Center USA, Inc. | 5.12 Million USD | 73.237% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 97.909% |
| IR-Med Inc. | 634 Thousand USD | -116.303% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 74.959% |
| Polarean Imaging plc | 2.58 Million USD | 46.857% |
| United American Healthcare Corporation | 119 Thousand USD | -1052.407% |
| ECGI Holdings, Inc. | 11.94 Million USD | 88.515% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 41.861% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -3.579% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 5.184% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -102.381% |
| Urologix, Inc. | 12.64 Million USD | 89.154% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 74.586% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 83.833% |
| SS Innovations International, Inc. | 11.18 Million USD | 87.735% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -161.02% |
| Smith & Nephew plc | 4.76 Billion USD | 99.971% |
| NIOX Group Plc | 9.8 Million USD | 86.009% |
| Fuse Medical, Inc. | 15.11 Million USD | 90.924% |
| Broncus Holding Corporation | 10.43 Million USD | 86.854% |
| Brain Scientific Inc. | 7.42 Million USD | 81.534% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 95.943% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -72.698% |